Literature DB >> 5126279

Neuroblastoma: an assessment of therapy in reference to staging.

C E Koop, D G Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5126279     DOI： 10.1016/0022-3468(71)90384-8

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN： 0022-3468            Impact factor:   2.545


× No keyword cloud information.
  9 in total

1.  Management of Wilms' tumor and neuroblastoma.

Authors:  P Mehta; T Vats
Journal:  Indian J Pediatr       Date:  1981 Jul-Aug       Impact factor: 1.967

2.  Spontaneous maturation of stage IV--S neuroblastoma.

Authors:  L Rangecroft; I Lauder; J Wagget
Journal:  Arch Dis Child       Date:  1978-10       Impact factor: 3.791

3.  Neuroblastoma: an analysis of 160 cases.

Authors:  J L Grosfeld; R L Baehner
Journal:  World J Surg       Date:  1980-01       Impact factor: 3.352

4.  Advances in the treatment of pediatric solid tumors: A 50-year perspective.

Authors:  Michael P LaQuaglia; Justin T Gerstle
Journal:  J Surg Oncol       Date:  2022-10       Impact factor: 2.885

5.  Prognostic value of different staging systems in neuroblastomas and completeness of tumour excision.

Authors:  N L Carlsen; I J Christensen; H Schroeder; P V Bro; U Hesselbjerg; K B Jensen; O H Nielsen
Journal:  Arch Dis Child       Date:  1986-09       Impact factor: 3.791

6.  PCNA levels in neuroblastoma are increased in tumors with an amplified N-myc gene and in metastatic stage tumors.

Authors:  D R Keim; N Hailat; R Kuick; C P Reynolds; G M Brodeur; R C Seeger; S M Hanash
Journal:  Clin Exp Metastasis       Date:  1993-01       Impact factor: 5.150

7.  Stage II neuroblastoma. Adverse prognostic significance of lymph node involvement.

Authors:  J Ninane; J Pritchard; P H Morris Jones; J R Mann; J S Malpas
Journal:  Arch Dis Child       Date:  1982-06       Impact factor: 3.791

8.  The impact of chemotherapy and radiation therapy on secondary operations for neuroblastoma.

Authors:  E I Smith; H F Krous; W P Tunell; D C Hitch
Journal:  Ann Surg       Date:  1980-05       Impact factor: 12.969

9.  Markedly improving survival of neuroblastoma: a 30-year analysis of 1,646 patients.

Authors:  Juan C Gutierrez; Anne C Fischer; Juan E Sola; Eduardo A Perez; Leonidas G Koniaris
Journal:  Pediatr Surg Int       Date:  2007-05-03       Impact factor: 2.003
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.